Call for Abstract

Experts Meet On Cancer Therapy 2018, will be organized around the theme “Sensible assembly on emerging prospects of cancer therapy”

Cancer Therapy 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer Therapy 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Difference between benign & malignant tumors
  • Track 1-2Apoptosis
  • Track 1-3Signs & Symptoms of cancer
  • Track 1-4Metastasis
  • Track 1-5Malignant neoplasm
  • Track 1-6Types of Cancers
  • Track 2-1Lung Cancer
  • Track 2-2Colo-rectal Cancer
  • Track 2-3Cervical Cancers
  • Track 2-4Breast Cancer
  • Track 2-5Liver Cancer
  • Track 2-6Stomach Cancer
  • Track 2-7Non-melanoma Skin Cancer
  • Track 2-8Bladder Cancer
  • Track 2-9Melanoma
  • Track 2-10Non-Hodgkin lymphoma
  • Track 3-1Cancer staging
  • Track 3-2Treatment of cancers based on stage of cancer
  • Track 3-3Cancer grading
  • Track 3-4TNM staging
  • Track 3-5Number system
  • Track 3-6Tests and procedures for detection of cancer staging
  • Track 4-1Chemicals
  • Track 4-2Exercise & Diet
  • Track 4-3Infection
  • Track 4-4Radiation
  • Track 4-5Heredity
  • Track 4-6Physical agents
  • Track 4-7Hormones
  • Track 4-8Autoimmune diseases
  • Track 4-9Genetic variations
  • Track 5-1Vaginal bleeding
  • Track 5-2Stage of signs & symptoms
  • Track 5-3Detection of signs & symptoms of cancers
  • Track 5-4Tests to be performed for detection of cancer
  • Track 5-5Prognosis of different cancers
  • Track 5-6Epidemiology of different cancers
  • Track 6-1The Gerson therapy and juicing
  • Track 6-2The bud wig protocol
  • Track 6-3Proteolytic enzyme therapy
  • Track 6-4Vitamin-C chelation
  • Track 6-5Frankincense essential oil Therapy
  • Track 6-6Probiotic foods and supplements
  • Track 6-7Sunshine & vitamin D3
  • Track 6-8Oxygen therapy and hyperbaric chambers
  • Track 7-1Surgery
  • Track 7-2Radiation therapy
  • Track 7-3Chemotherapy
  • Track 7-4Targeted therapy
  • Track 7-5Immunotherapy
  • Track 7-6Hormonal therapy
  • Track 7-7Angiogenesis inhibitors
  • Track 7-8Synthetic lethality
  • Track 8-1Laparoscopic surgeries
  • Track 8-2Laser surgery
  • Track 8-3Cryo surgery
  • Track 8-4Mohs micrographic surgery/microscopically controlled surgery
  • Track 8-5Endoscopy
  • Track 9-1CT scan
  • Track 9-2Magnetic Resonance Imaging
  • Track 9-3Magnetic Resonance Imaging
  • Track 9-4Positron emission tomography
  • Track 9-5Simulation
  • Track 9-6Dosimetrists
  • Track 10-1CG0070 (Bladder)
  • Track 10-2Reolysin (prostate, colorectal, ovarian, lung and breast cancer)
  • Track 10-3CAVATAK (melanoma)
  • Track 10-4JX-594 (ovarian)
  • Track 10-5MV-NIS (multiple myeloma)
  • Track 10-6T-VEC (melanoma)
  • Track 11-1ER-positive cancers
  • Track 11-2PR-positive cancers
  • Track 11-3Adjuvant therapy
  • Track 11-4Neo-adjuvant therapy
  • Track 11-5Breast cancer hormone therapy
  • Track 11-6Prostate cancer hormone therapy
  • Track 11-7Womb cancer hormone therapy